Todd Anderman's most recent trade in Ocular Therapeutix Inc was a trade of 197,650 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Todd Anderman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 197,650 | 197,650 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Todd Anderman | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 64,900 | 152,468 (0%) | 0% | 0 | Common Stock | |
| Ocular Therapeutix Inc | Todd Anderman | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.34 per share. | 08 Oct 2025 | 11,132 | 87,568 (0%) | 0% | 12.3 | 137,369 | Common Stock |
| Ocular Therapeutix Inc | Todd Anderman | Chief Legal Officer | 07 Oct 2024 | 296,500 | 296,500 | - | - | Stock Option (Right to Buy) | ||
| Ocular Therapeutix Inc | Todd Anderman | Chief Legal Officer | 07 Oct 2024 | 98,700 | 98,700 (0%) | 0% | 0 | Common Stock |